AQ001S

AQ001S · Aquilon Pharmaceuticals S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AQ001S, covering 2024-09-03 to 2024-09-03. Get the full timeline:

Most recent: Clinical Trial Update: Crossover Trial to Assess Efficacy and Safety of Inhaled AQ001S Compared to a Budesonide Suspension in Mild Asthmatics [Phase 1, Phase 2]

See pricing